About Annovis Bio, Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Market Cap
$0.04B
Employees
6
Listed Since
January 29, 2020
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.annovisbio.comPhone
484-875-3192
Headquarters
101 LINDENWOOD DRIVE, SUITE 225
MALVERN, PA 19355
CIK
0001477845